OneMedNet Corp 8-K

What Happened
OneMedNet Corporation (ONMD) reported in an 8-K filed April 20, 2026 that on April 14, 2026 it received a notice from Nasdaq’s Listing Qualifications staff saying the company is not meeting the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq determined OneMedNet’s closing bid price was below $1.00 for the last 30 consecutive business days. The company has 180 calendar days—until October 12, 2026—to regain compliance by having a closing bid of at least $1.00 per share for 10 consecutive business days.

Key Details

• Notice received: April 14, 2026; 8-K filed April 20, 2026.
• Compliance window: 180 calendar days, until October 12, 2026.
• Regain requirement: minimum $1.00 closing bid for at least 10 consecutive business days.
• Potential second period: Company could be eligible for an additional 180-day cure period if it meets Nasdaq’s market value and other initial listing standards (except the bid price) and provides written notice—may require a reverse stock split.
• Company action: OneMedNet says it will monitor the stock price and may consider options, including a reverse stock split, to try to regain compliance.

Why It Matters
A failure to regain compliance could lead Nasdaq to begin delisting proceedings, which can reduce liquidity, limit investor access, and negatively affect the stock price. The company has a defined cure period and options (including a possible reverse split) to address the deficiency, but there is no guarantee it will succeed. Investors should monitor updates from OneMedNet for any corrective actions, proxy notices, or further Nasdaq communications.